9 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Highness Implant System
FDA 510(k)
FDA Class 2
·Dental
ALLOX2 TISSUE EXPANDERS
FDA 510(k)
FDA Unclassified
·Unknown
TRIFLANGE II ACETABULAR CUP SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
ACCU-CHEK COMFORT CURVE
FDA Adverse Event
Malfunction
·*·Product code LFR·February 6, 2006
COLLEAGUE 3 VOLUMETRIC INFUSION PUMP
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE PTE. LTD.·Product code FRN·November 25, 2008
OT ULTRALINK METER
FDA Adverse Event
Malfunction
·LIFESCAN INC.·Product code NBW·September 9, 2011
HIRES 90K ADVANTAGE IMPLANT
FDA Adverse Event
Injury
·ADVANCED BIONICS LLC·Product code MCM·July 18, 2013
BI-MENTUM REVISION CUP 55
FDA Adverse Event
Injury
·S.E.R.F SOCIETE DETUDES RECHERCHE FABRICATION·Product code MEH·January 24, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014